Editorial: Co-morbidity of COVID 19 and fungal infections
Front Fungal Biol
.
2024 Sep 16:5:1462172.
doi: 10.3389/ffunb.2024.1462172.
eCollection 2024.
Authors
Ramendra Pati Pandey
1
,
Ruby Dhiman
1
,
Vivek Mishra
2
,
V Samuel Raj
3
,
Chung-Ming Chang
4
5
Affiliations
1
School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.
2
Amity Institute of Click-Chemistry Research and Studies (AICCRS), Amity University Uttar Pradesh, Noida, India.
3
Centre for Drug Design Discovery and Development (C4D), SRM University, Sonepat, Haryana, India.
4
Master & Ph.D. Program in Biotechnology Industry, Chang Gung University, Taoyuan, Taiwan.
5
Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, Taiwan.
PMID:
39351259
PMCID:
PMC11439790
DOI:
10.3389/ffunb.2024.1462172
No abstract available
Keywords:
COVID-19; clinical management; co-morbidity; fungal infections; morbidity and mortality.
Publication types
Editorial